Carregant…
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
BACKGROUND: Folate receptor 1 (FOLR1) is expressed in the majority of ovarian carcinomas (OvCa), making it an attractive target for therapy. However, clinical trials testing anti-FOLR1 therapies in OvCa show mixed results and require better understanding of the prognostic relevance of FOLR1 expressi...
Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Online Article Text |
Idioma: | English |
Publicat: |
Nature Publishing Group
2014
|
Matèries: | |
Accés en línia: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264456/ https://www.ncbi.nlm.nih.gov/pubmed/25349970 http://dx.doi.org/10.1038/bjc.2014.567 |